Three aberrant splicing variants of the HMGIC gene transcribed in uterine leiomyomas

• Published in: Genes chromosomes & cancer 2001-02, Vol.30 (2), p.212-217
• Main Authors: Kurose, Keisuke, Mine, Nobuya, Iida, Aritoshi, Nagai, Hisaki, Harada, Haruhito, Araki, Tsutomu, Emi, Mitsuru
• Format: Article
• Language: English
• Subjects: Alternative Splicing - genetics; DNA, Complementary - analysis; Female; Gene Amplification; Genes, Neoplasm - genetics; Genetic Variation; High Mobility Group Proteins - genetics; HMGA2 Protein; Humans; Leiomyoma - genetics; Nucleic Acid Amplification Techniques; Oncogene Proteins, Fusion - genetics; Protein Isoforms - genetics; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion; Transcription, Genetic; Uterine Neoplasms - genetics
• ISSN: 1045-2257; 1098-2264
• DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1081>3.0.CO;2-S

Cytogenetic aberrations involving chromosome region 12q13–15 occur frequently among benign mesenchymal tumors in humans, e.g., pleomorphic adenomas of the parotid gland, pulmonary chondroid hamartomas, lipomas, or uterine leiomyomas. HMGIC, a gene encoding a protein of the high‐mobility group, has been identified as a target of those events. Using the 3′ rapid amplification of cDNA ends (RACE) technique, we identified six different fusion transcripts of the HMGIC gene among 13 uterine leiomyomas; three of these variants had not been described before. Radiation‐hybrid mapping located all three of the novel fusion transcripts in the same chromosomal region as the HMGIC gene. Cloning of the entire HMGIC gene in a genomic contig of P1‐derived artificial chromosomes and cosmids revealed that the 3′ portion of each novel fusion transcript contained cryptic exonic sequences (designated a, b, and c) present in intron 3 of the HMGIC gene. Thus, aberrant alternative splicing was responsible for abnormal HMGIC isoforms in those myomas. Identification of these novel variants suggested that aberrant splicing can join chromosomal translocation and inversion as a mechanism for producing abnormal HMGIC transcripts, and that separation of the DNA binding domains of HMGIC from its acidic carboxyl‐terminal regulatory domain can lead to development of benign mesenchymal tumors. © 2000 Wiley‐Liss, Inc.